Literature DB >> 6806334

Anticoagulant antibodies in the synovial membranes of patients suffering from haemophilia, rheumatoid arthritis and other rheumatic disorders.

S G Rainsford, A Aronstam, E J Holborow, D S McLellan.   

Abstract

This study has identified IgG and IgM anticoagulant antibodies in the synovial membranes of patients suffering from haemophilia and rheumatoid arthritis (RA) but not in synovial tissues from normal subjects or in patients with other arthritides. In the majority of cases the antibody appeared to have the specificity of the lupus-like anticoagulant (LLA) seen in patients with systemic lupus erythematosus (SLE). The importance of these findings with regard to the treatment of certain cases of haemophilia and RA and the possible relation between the presence of these antibodies and viral infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806334      PMCID: PMC497748          DOI: 10.1136/jcp.35.6.673

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Clinical observations and their relationship to laboratory findings in the haemophilias.

Authors:  S G Rainsford; A Hall
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

2.  Letter: Detection and measurement of factor VIII antibodies in an agarose gel: a modified method.

Authors:  S G Rainsford; A Hall
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

3.  Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies.

Authors:  P Bird
Journal:  Br J Haematol       Date:  1975-02       Impact factor: 6.998

4.  Haemophilia Centre Director's annual statistics for 1975.

Authors:  R Biggs; R J Spooner
Journal:  Br J Haematol       Date:  1977-07       Impact factor: 6.998

5.  Association between hepatitis B virus and essential mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; D Zucker-Franklin; E C Franklin
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

6.  A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination.

Authors:  R N Poston
Journal:  J Immunol Methods       Date:  1974-05       Impact factor: 2.303

7.  The treatment of patients who have factor-VIII antibodies.

Authors:  C R Rizza; R Biggs
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

8.  Circulating anticoagulant against Factor XII and platelet antibodies in systemic lupus erythematosus.

Authors:  G M Gandolfo; A Afeltra; A Amoroso; F Biancolella; G M Ferri
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

9.  Isolation of IgG3 from normal human sera and from a patient with multiple myeloma by using protein A-sepharose 4B.

Authors:  H Hjelm
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

10.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.